Fresenius Analysis

Fresenius is a global healthcare company headquartered in Germany, specializing in products and services for chronically and critically ill patients. Their unique approach combines advanced medical technology with a commitment to improving patient outcomes and access to healthcare. This enables them to deliver innovative solutions that enhance the quality of care across various healthcare settings.

Administer biopharmaceuticals to critically ill patients; Provide clinical nutrition for patients with specific dietary needs; Operate private hospitals delivering comprehensive healthcare services; Develop biosimilars to improve treatment affordability; Enhance patient safety through rigorous quality assurance.

Generated €21.5 billion in revenue in 2024; Employs over 176,000 people globally; Largest shareholder is the Else Kröner-Fresenius Foundation.